Orlip X 120mg Capsule contains Orlistat, a potent lipase inhibitor indicated for the management of obesity. Orlistat acts locally in the gastrointestinal tract by selectively inhibiting pancreatic and gastric lipases, enzymes responsible for the hydrolysis of dietary triglycerides into absorbable free fatty acids and monoglycerides. By preventing the breakdown and subsequent absorption of approximately 30% of dietary fat, Orlistat facilitates weight reduction in conjunction with a reduced-calorie diet and lifestyle modifications. The medication is prescribed for adults with a body mass index (BMI) of 30 kg/m² or greater, or those with a BMI of 27 kg/m² or greater in the presence of other risk factors such as hypertension, diabetes mellitus, or dyslipidemia. Clinical studies have demonstrated that Orlistat, when combined with diet and exercise, significantly improves weight loss outcomes and contributes to the reduction of obesity-related comorbidities. Common adverse effects are primarily gastrointestinal, including oily spotting, flatulence with discharge, and fecal urgency, which are generally mild and related to dietary fat intake. Orlip X should be used cautiously in patients with malabsorption syndromes or cholestasis and is contraindicated during pregnancy and lactation. Regular monitoring of liver function and fat-soluble vitamin levels is recommended during prolonged therapy.